GSA CAPITAL PARTNERS LLP - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$255,000
+83.5%
203,815
+44.8%
0.02%
+88.9%
Q2 2017$139,000
+39.0%
140,715
+877.8%
0.01%
+50.0%
Q1 2016$100,000
+6.4%
14,391
+13.3%
0.01%
-14.3%
Q4 2013$94,00012,7000.01%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Abingworth LLP 327,350$2,943,0001.62%
HealthCor Management, L.P. 1,575,000$14,207,0000.86%
Cormorant Asset Management, LP 200,000$1,804,0000.42%
BVF INC/IL 184,999$1,669,0000.26%
Verity Asset Management, Inc. 28,410$244,0000.25%
Callan Capital, LLC 80,478$726,0000.24%
MARXE AUSTIN W & GREENHOUSE DAVID M 225,000$2,029,0000.22%
EMERALD MUTUAL FUND ADVISERS TRUST 61,846$558,0000.05%
LMR Partners LLP 11,815$106,0000.02%
Weiss Multi-Strategy Advisers LLC 70,000$631,0000.01%
View complete list of REGULUS THERAPEUTICS INC shareholders